p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging

Stem Cell Reports. 2014 Dec 9;3(6):1085-102. doi: 10.1016/j.stemcr.2014.10.005. Epub 2014 Nov 20.

Abstract

Hematopoietic stem cells (HSCs) are characterized by the capacity for self-renewal and the ability to reconstitute the entire hematopoietic compartment. Thrombopoietin maintains adult HSCs in a quiescent state through the induction of cell cycle inhibitors p57(Kip2) and p19(INK4d). Using the p19(INK4d-/-) mouse model, we investigated the role of p19(INK4d) in basal and stress-induced hematopoiesis. We demonstrate that p19(INK4d) is involved in the regulation of HSC quiescence by inhibition of the G0/G1 cell cycle transition. Under genotoxic stress conditions, the absence of p19(INK4d) in HSCs leads to accelerated cell cycle exit, accumulation of DNA double-strand breaks, and apoptosis when cells progress to the S/G2-M stages of the cell cycle. Moreover, p19(INK4d) controls the HSC microenvironment through negative regulation of megakaryopoiesis. Deletion of p19(INK4d) results in megakaryocyte hyperproliferation and increased transforming growth factor β1 secretion. This leads to fibrosis in the bone marrow and spleen, followed by loss of HSCs during aging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow / metabolism
  • Bone Marrow / pathology
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / metabolism
  • Cell Count
  • Cell Differentiation / genetics
  • Cell Lineage / genetics
  • Cellular Senescence / genetics*
  • Cyclin-Dependent Kinase Inhibitor p19 / deficiency
  • Cyclin-Dependent Kinase Inhibitor p19 / genetics*
  • Cyclin-Dependent Kinase Inhibitor p19 / metabolism
  • DNA Damage*
  • Hematopoiesis
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / metabolism*
  • Mice
  • Mice, Knockout
  • Osteosclerosis / genetics
  • Osteosclerosis / pathology
  • Primary Myelofibrosis / genetics
  • Primary Myelofibrosis / pathology
  • Resting Phase, Cell Cycle / genetics
  • Stem Cell Niche / genetics*
  • Stromal Cells / metabolism

Substances

  • Cyclin-Dependent Kinase Inhibitor p19